• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Global Electrophysiology Ablation Catheters Market 2014-2018 - Product Image

Global Electrophysiology Ablation Catheters Market 2014-2018

  • ID: 2884212
  • June 2014
  • Region: Global
  • 71 Pages
  • TechNavio
The global electrophysiology ablation catheters market is set to grow at a CAGR of percent over the period 2013-2018.

FEATURED COMPANIES

  • AtriCure Inc.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corp.
  • CardioFocus Inc.
  • Johnson & Johnson
  • Medtronic Inc.
  • MORE

Catheter ablation is a minimally invasive procedure used to remove or destroy faulty electrical pathways from sections of the heart that promote irregular cardiac rhythms (also known as cardiac arrhythmias). Cardiac arrhythmias can be of several types, including atrial fibrillation, atrial flutter, and supraventricular tachycardia. Atrial fibrillation is the most common type of cardiac arrhythmia prevalent among the global population. EP ablation catheters are devices used to treat cardiac arrhythmias. These catheters destroy the faulty tissue with the use heat energy generated from RF, laser and microwave radiation or by freezing the abnormal tissue.

The global electrophysiology ablation catheters market can be segmented into five divisions: RF Ablation EP Catheters, Cryoablation EP Catheters, Laser Ablation Systems, Microwave Ablation EP Catheters, and Navigational Advanced Mapping Accessories.

The Global Electrophysiology Ablation Catheters Market 2014-2018 report, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Electrophysiology Ablation READ MORE >

The global electrophysiology ablation catheters market is set to grow at a CAGR of percent over the period 2013-2018.

FEATURED COMPANIES

  • AtriCure Inc.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corp.
  • CardioFocus Inc.
  • Johnson & Johnson
  • Medtronic Inc.
  • MORE

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05. Introduction

06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07. Market Segmentation by Technology

08. Geographical Segmentation

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.1.2 Mergers and Acquisitions
16.2 Vendor Analysis 2013
16.3 Other Prominent Vendors

17. Key Vendor Analysis
17.1 Boston Scientific Corp.
17.1.1 Key Facts
17.1.2 Business Overview
17.1.3 Business Segmentation
17.1.4 Business Segmentation by Revenue 2013
17.1.5 Business Segmentation by Revenue 2012 and 2013
17.1.6 Sales by Geography
17.1.7 Business Strategy
17.1.8 Key Developments
17.1.9 SWOT Analysis
17.1.10 Strengths
17.1.11 Weaknesses
17.1.12 Opportunities
17.1.13 Threats
17.2 Johnson and Johnson Ltd.
17.2.1 Key Facts
17.2.2 Business Overview
17.2.3 Business Segmentation by Revenue 2013
17.2.4 Business Segmentation by Revenue 2012 and 2013
17.2.5 Sales by Geography
17.2.6 Business Strategy
17.2.7 Key Information
17.2.8 SWOT Analysis
17.2.9 Strengths
17.2.10 Weaknesses
17.2.11 Opportunities
17.2.12 Threats
17.3 Medtronic Inc.
17.3.1 Key Facts
17.3.2 Business Overview
17.3.3 Business Segmentation
17.3.4 Business Segmentation by Revenue 2013
17.3.5 Business Segmentation by Revenue 2012 and 2013
17.3.6 Sales by Geography
17.3.7 Business Strategy
17.3.8 Key Developments
17.3.9 SWOT Analysis
17.3.10 Strengths
17.3.11 Weaknesses
17.3.12 Opportunities
17.3.13 Threats
17.4 St. Jude Medical Inc.
17.4.1 Key Facts
17.4.2 Business Overview
17.4.3 Business Segmentation
17.4.4 Business Segmentation by Revenue 2013
17.4.5 Sales by Geography
17.4.6 Business Strategy
17.4.7 Key Information
17.4.8 SWOT Analysis
17.4.9 Strengths
17.4.10 Weaknesses
17.4.11 Opportunities
17.4.12 Threats

18. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology
Exhibit 2: Global EP Ablation Catheters Market 2013-2018 (US$ million)
Exhibit 3: Global EP Ablation Catheters Market Segmentation by Technology
Exhibit 4: Global EP Ablation Catheters Market Segmentation by Technology
Exhibit 5: Global EP Ablation Catheters Market by Geographical Segmentation 2013
Exhibit 6: Boston Scientific Corp.: Business Segmentation 2013
Exhibit 7: Boston Scientific Corp.: Business Segmentation by Revenue 2013
Exhibit 8: Boston Scientific Corp.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 9: Boston Scientific Corp.: Sales by Geography 2013
Exhibit 10: Johnson and Johnson Ltd.: Business Segmentation by Revenue 2013
Exhibit 11: Business Segmentation by Revenue 2012 and 2013US$ billions
Exhibit 12: Johnson and Johnson Ltd.: Sales by Geography 2013
Exhibit 13: Exhibit 1: Medtronic Inc.: Business Segmentation 2013
Exhibit 14: Exhibit 2: Medtronic Inc.: Business Segmentation by Revenue 2013
Exhibit 15: Exhibit 3: Medtronic Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 16: Exhibit 4: Medtronic Inc.: Sales by Geography 2013
Exhibit 17: St. Jude Medical Inc.: Business Segmentation
Exhibit 18: St. Jude Medical Inc.: Business Segmentation by Revenue 2013
Exhibit 19: St. Jude Medical Inc.: Sales by Geography 2013

The global electrophysiology ablation catheters market is set to grow at a CAGR of percent over the period 2013-2018.

FEATURED COMPANIES

  • AtriCure Inc.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corp.
  • CardioFocus Inc.
  • Johnson & Johnson
  • Medtronic Inc.
  • MORE

The following companies are recognised as the key players in Global Electrophysiology Ablation Catheters Market: Boston Scientific Corp., Johnson &Johnson, Medtronic Inc. , St. Jude Medical Inc., Advanced Cardiac Therapeutics Inc. , AtriCure Inc., BIOTRONIK SE & Co. KG, CardioFocus Inc., Edwards Lifesciences Corp., Imricor Medical Systems Inc., MicroPort Scientific Corp., PLC Medical Systems Inc., VIMECON GmbH.

Commenting on the report, an analyst from the team said: “There has been an increase in the adoption of irrigated-tip ablation catheters used in cardiac ablation procedures to treat atrial fibrillation. Irrigated-tip ablation catheters overcome the limitations of non-irrigated ablation catheters by lowering the temperature of the electrode and tissue surface, thereby, increasing the efficacy of the power delivery with safety and reduced coagulum formation at the catheter tip. Some of the irrigated-tip EP ablation catheters available in the market include ThermoCool irrigated tip catheter, offered by Biosense Webster, and Blazer open-irrigated ablation catheter, offered by Boston Scientific.”

According to the report, the Global EP Ablation Catheters market is driven by several factors, including the incidence of cardiac arrhythmias; atrial fibrillation has increased the demand for EP ablation catheters.

Furthermore, the report states that the alternative treatment available for cardiac arrhythmias such as drug therapy is one of the major challenges.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

The global electrophysiology ablation catheters market is set to grow at a CAGR of percent over the period 2013-2018.

- Advanced Cardiac Therapeutics Inc.
- AtriCure Inc.
- BIOTRONIK SE & Co. KG
- Boston Scientific Corp.
- CardioFocus Inc.
- Edwards Lifesciences Corp.
- Imricor Medical Systems Inc.
- Johnson & Johnson
- Medtronic Inc.
- MicroPort Scientific Corp.
- PLC Medical Systems Inc.
- St. Jude Medical Inc.
- VIMECON GmbH

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos